公开(公告)号：WO2021032441A1

公开(公告)日：2021-02-25

申请号：PCT/EP2020/071658

申请日：2020-07-31

Applicant: SIEMENS HEALTHCARE GMBH ,  THE CLEVELAND CLINIC FOUNDATION

Inventor： DIETRICH, Carsten ,  SIEBERT, Matthias ,  ABAZEED, Mohamed ,  GEORGI, Jens-Christoph ,  WEHNER, Heike ,  KAPPEL, Andreas ,  MATZAS, Mark ,  POSCH, Andreas Emanuel

IPC: C12Q1/6886

Abstract: The present invention relates to methods of predicting a radiotherapy success in a method of treating a lung cancer of a patient, the use of specific markers for predicting a radiotherapy success in a method of treating a lung cancer of a patient, a database comprising the markers, and a computer program product for use in such a method.

公开(公告)号：WO2018114243A1

公开(公告)日：2018-06-28

申请号：PCT/EP2017/080666

申请日：2017-11-28

Applicant: SIEMENS HEALTHCARE GMBH

Inventor： DIETRICH, Carsten ,  HUANG, Yiwei ,  MATZAS, Mark ,  POSCH, Andreas Emanuel

IPC: C12Q1/68 ,  C12Q1/70 ,  G06F19/22

Abstract: The present invention relates to a method of selectively amplifying at least one nucleic acid sequence of at least one microorganism and/or virus in a sample of a subject, wherein k-mers (3) are applied that show a difference in frequency and/or context in the genome (2) of the at least one microorganism and/or virus compared to the genome of the subject (1).